|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's Range||144.12 - 145.75|
|52 Week Range||109.16 - 157.00|
|Beta (5Y Monthly)||0.69|
|PE Ratio (TTM)||22.73|
|Earnings Date||Oct 13, 2020|
|Forward Dividend & Yield||4.04 (2.80%)|
|Ex-Dividend Date||Aug 24, 2020|
|1y Target Est||166.18|
The U.K. is set to launch the first coronavirus human challenge trial, which will infect volunteers with a small portion of the disease so as to create a wider pool to test a vaccine, in January. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus.
Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and discuss the latest in the COVID-19 vaccine race.
COMPANY CLOSE UPDATES Terrence Horan Shares of Johnson & Johnson JNJ inched 0.16% higher to $144.55 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.